Maeda Makiko, Fujio Yasushi, Azuma Junichi
Department of Clinical Pharmacogenomics, School of Pharmacy, Hyogo University of Health Sciences.
Nihon Rinsho. 2011 Oct;69(10):1887-90.
Smoking cessation is extremely important to prevent the development of the serious diseases, such as COPD and cancers. Absorbed nicotine through smoking into the body is mainly metabolized by cytochrome P450 (CYP) 2A6. On the other, the nicotine acts in the brain through neuronal nicotinic acetylcholine receptors (nAChRs), which regulate the addictive properties of nicotine. Many associated studies have implicated genetic backgrounds influence smoking behavior and nicotine dependence. In these concepts, we here discuss the genes related to nicotine dependence from the pharmacokinetic and pharmacodynamic aspects of nicotine. Referring to the genome association studies, better understanding the molecular mechanisms of nicotine dependence would help to design targeted, more effective therapies for the tobacco-related diseases and smoking cessation program.
戒烟对于预防诸如慢性阻塞性肺疾病(COPD)和癌症等严重疾病的发展极为重要。通过吸烟摄入体内的尼古丁主要由细胞色素P450(CYP)2A6代谢。另一方面,尼古丁通过神经元烟碱型乙酰胆碱受体(nAChRs)在大脑中发挥作用,这些受体调节尼古丁的成瘾特性。许多相关研究表明遗传背景会影响吸烟行为和尼古丁依赖。基于这些概念,我们在此从尼古丁的药代动力学和药效学方面讨论与尼古丁依赖相关的基因。参考全基因组关联研究,更好地理解尼古丁依赖的分子机制将有助于设计针对烟草相关疾病的靶向、更有效的治疗方法以及戒烟计划。